• Letter from the Editor
  Health, Vision, and Policy

• The Global HIV/AIDS Epidemic
  

• Feasible Microbicides Remain Elusive

• Issues in HIV Postexposure Prophylaxis

• The Wide-Ranging Effects of Nucleoside Analogs
  A Look at Mitochondrial Toxicity

Departments

• BETA News Briefs

• Drug Watch
  Lopinavir: The Most Potent Protease Inhibitor

• Women and HIV
  • Re-examining Treatment Recommendations for Women
  • Women and HIV/AIDS: Key Facts and Issues

• Conference Coverage
  3^rd International Workshop on Salvage Therapy for HIV Infection

• Quick Reference Guides
  • AIDS-related Web Sites
  • AIDS Drug Assistance Programs by State

• Glossary

Notice

The statements and opinions in BETA are published as an educational resource only, and do not imply recommendation or endorsement by BETA or the San Francisco AIDS Foundation. Always consult a physician before taking any drug or changing a drug regimen.

Bulletin of Experimental Treatments for AIDS Editor: Leslie Hanna Contributors to this issue: Kathryn Anastos, MD, Joshua D. Bamberger, MD, MPH, Harvey S. Bartnof, MD, Nicholas Cheonis, Dave Gilden, Leslie Hanna, Liz Highleyman, Kimberly Page-Shafer, PD, MPH, David Townley Scientific Advisory Committee: Kirsten Balano, PharmD, Harvey S. Bartnof, MD, Gregory Pauxtis, MD, Mary Romeyn, MD Copyright BETA is published quarterly by the San Francisco AIDS Foundation. Funding provided by private and corporate donations. Copyright © 2000 by the San Francisco AIDS Foundation. All rights reserved. Articles may be reproduced for free distribution with acknowledgment of BETA and the author(s); for other uses, contact the editors. Brief passages may be quoted for review. Library of Congress ISSN 1058-708X. SFAF Bulletin of Experimental Treatments for AIDS 995 Market St #200 San Francisco, CA 94103 Subscription Office: (800) 959-1059 Editorial/content: (415) 487-8060 Fax: (415) 487-8069 E-mail: beta@sfaf.org Web: www.sfaf.org ©2000 San Francisco AIDS Foundation